PRELIMINARY PROGRAM
Thursday, 10th September 2026
Workshop: Phosphoproteomics & Pathways Mapping
09:00-09:15 Welcome & Introduction
09:15-10:15 Module 1: Phosphoproteomics workflow & dataset exploration
10:15-10:30 Coffee-break / Networking
10:30-12:00 Module 2: Live-cell imaging (pre-recorded movies, quantify dynamics)
Conference sessions
13:00-14:00 Registration
14:00-14:30 Opening session
Odete da Cruz e Silva, iBiMED
Session 1 Signalling in health and disease
14:30-15:00 A proinflammatory response triggered by bisphenol compounds in a Caco-2/THP-1 Co-culture Model
Peter Jordan, INSA
15:00-15:30 Host-Virus interplay in SARS-CoV-2 infection: protein phosphatase 1
interactions with viral proteins
Margarida Fardilha, iBiMED
15:30-16:30 Coffee-break and poster session
16:30-16:50 Proteomics-based approaches for biomarkers discovery in myotonic dystrophy
type 1
Sandra Rebelo, iBiMED
Selected short talks:
16:50-17:00 Post-transcriptional control by ZFP36 RNA-binding proteins sustains thymic
epithelial cell differentiation and thymic function
Francisco Sobral, i3S
17:00-17:10 LAMP2 controls autophagy-lysosomal pathway for self-peptide–MHC II
processing in thymic epithelial cells to tune CD4 T-Cell Selection
João Cardoso, i3S
17:10-17:20 AMPK couples cellular energy sensing to mitochondria–ER contact site
dynamics
Pedro Dionísio, MIA
17:20-17:30 Sialyl Lewis X expression in Parkinson's disease
Margarida Castro-Caldas, UCIBIO
17:30-17:40 The APP phospho-S655 interactome during neuronal differentiation
David Almeida, iBiMED
19:00 Networking and dinner
Friday, 11th September 2026
08:30-09:30 Registration
Keynote conference 1
09:30-10:30 Modeling Parkinson's disease to uncover new therapeutic targets for non-
motor symptoms and complications
Gilberto Fisone, Karolinska Institutet
10:30-11:30 Coffee-break and poster session
Session 2 Diagnostic and therapeutic targets
11:30-11:50 PSGL-1 expression and activation in B-cell lymphoma: a marker for
immunotherapy
Nuno Santos, i3S
Selected short talks:
11:50-12:00 From Gut to Brain: Unraveling the Role of miR-486-5p in Parkinson's Disease
Beatriz Guedes, CNC
12:00-12:10 MRP8 as a Tumor-Promoting Inflammatory Vulnerability in Pancreatic Ductal Adenocarcinoma
Juliana Medeiros, i3S
12:10-12:20 3D chromatin remodeling as a targetable vulnerability of KRAS inhibition-
tolerant colorectal cancer cells
Sérgia Velho, UCIBIO
12:30-14:30 Lunch
Keynote conference 2
14:30-15:30 From chemical probes to drug discovery
Edward Tate, Imperial College London
Session 3 Innovative technologies in signalling
Selected short talks:
15:30-15:40 The v-ATPase Proximal Interactome in Neurons: A New Resource for
Understanding Ageing and Synaptic Vulnerability
Ivan L. Salazar, MIA - CIBB
15:40-15:50 Unveiling the mechanisms underlying Foxn1 expression in Thymic Epithelial
Cells
Ana Moreira, i3S
15:50-16:00 Defining the Role and Therapeutic Potential of NK Cells in Metastatic Pancreatic Ductal Adenocarcinoma
Rúben Mariano, i3S
16:00-16:10 Self-antigen presentation facilitates T-cell leukemia development in a TCR
transgenic mouse model
Marina Baessa, i3S
16:10-16:40 Coffee-break
16:45-17:00 Innovative technologies in cell signalling: a practical outlook
Alexandre Borges, Paralab S.A.
17:05-17:15 Get REAL: new fluorochrome solutions for flow cytometry
Alexandre Salvador, Enzifarma
17:15-17:35 New therapeutic strategies in T-cell Acute Lymphoblastic Leukemia
Rita Fragoso, GIMM
17:35-17:55 Peroxisomal antiviral signalling as a platform for the development of novel
broad-spectrum host‑directed antiviral therapies
Daniela Ribeiro, iBiMED
17:55-18:15 Closing session and distinctions
Funding
iBiMED
Este evento é financiado por fundos nacionais através da FCT - Fundação para a Ciência e a Tecnologia, I.P., no âmbito do projeto/apoio UID/04501/2025.
.png)
